These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38696421)

  • 1. The influence of non-state-owned shareholder governance on the governance level of state-owned enterprises--Based on the perspective of board resolution behavior and party organization governance.
    Zhang Z; Zhang L; Xiong A
    PLoS One; 2024; 19(5):e0301788. PubMed ID: 38696421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-ownership reform and strategic choice of Chinese state-owned enterprises.
    Yuan R; Li C; Sun X; Khaliq N
    PLoS One; 2023; 18(4):e0284722. PubMed ID: 37083868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Governance of non-state-owned shareholders and corporate capital structure decision: A mechanism test from the opportunistic behavior of management.
    Wang J; Hu Y; Liao F; Xu S
    PLoS One; 2023; 18(1):e0281120. PubMed ID: 36706148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental disclosure practices in mixed ownership models: A study of Chinese private enterprises.
    Song T; Xiong A
    PLoS One; 2023; 18(11):e0295399. PubMed ID: 38033167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the ownership balance and the efficiency of mixed ownership enterprises from the perspective of heterogeneous shareholders.
    Yin Z; Liu L; Wang H; Wen F
    PLoS One; 2018; 13(4):e0194433. PubMed ID: 29614126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESG performance, capital financing decisions, and audit quality: empirical evidence from Chinese state-owned enterprises.
    Zahid RMA; Saleem A; Maqsood US
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):44086-44099. PubMed ID: 36681761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corporate governance for sustainable development in Vietnam: Criteria for SOEs based on MCDM approach.
    Hoang PD; Nguyen LT; Tran BQ; Ta DT
    PLoS One; 2024; 19(5):e0302306. PubMed ID: 38691569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naive independent directors, corporate governance and firm performance.
    Chen G; Chen X; Wan P
    Front Psychol; 2022; 13():984661. PubMed ID: 36118473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of mixed-ownership reform on zombie firms: Evidence from Chinese listed SOEs.
    Yin Y; Cao K
    PLoS One; 2024; 19(7):e0301048. PubMed ID: 38959261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting or Inhibiting? The Impact of Environmental Regulation on Corporate Financial Performance-An Empirical Analysis Based on China.
    Deng X; Li L
    Int J Environ Res Public Health; 2020 May; 17(11):. PubMed ID: 32481632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corporate governance and shareholders' confidence in cooperatives: a systematic literature review.
    Thangaveloo A; Dorasamy M; Bin Ahmad AA; Marimuthu SB; Jayabalan J
    F1000Res; 2022; 11():144. PubMed ID: 38434005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How mixed ownership affects investment efficiency? evidence from state-owned enterprises in China.
    Huo X; Zhao Y; Dong Z
    PLoS One; 2024; 19(6):e0306190. PubMed ID: 38917198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big data empowerment: Digital transformation and governance of minority shareholders: Evidence from China.
    Hou X; Tang Y
    PLoS One; 2024; 19(4):e0302268. PubMed ID: 38625977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sincerity or hypocrisy: can green M&A achieve corporate environmental governance?
    Zhao X; Jia M
    Environ Sci Pollut Res Int; 2022 Apr; 29(18):27339-27351. PubMed ID: 34978031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the largest private shareholder on bank loans: Evidence from China.
    Liu J; Xu L; Zhang Q
    PLoS One; 2022; 17(10):e0276877. PubMed ID: 36301955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?-Empirical Evidence From COVID-19.
    Li J; Ma Y; Shi B; Yang Y
    Front Public Health; 2021; 9():812253. PubMed ID: 35155358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Mixed-Ownership Reform on Innovation Performance of Manufacturing Companies: Evidence from China.
    Xia W; Chen X; Wang G
    Comput Intell Neurosci; 2022; 2022():3809829. PubMed ID: 35785061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two tigers cannot live on the same mountain: The impact of the second largest shareholder on controlling shareholder's tunneling behavior.
    Liao J; Zhan Y; Zhao X
    PLoS One; 2023; 18(6):e0287642. PubMed ID: 37379292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corporate governance in Czech hospitals after the transformation.
    Pirozek P; Komarkova L; Leseticky O; Hajdikova T
    Health Policy; 2015 Aug; 119(8):1086-95. PubMed ID: 26001299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Facility Ownership on Utilization of Arthroscopic Shoulder Surgery.
    Black EM; Reynolds J; Maltenfort MG; Williams GR; Abboud JA; Lazarus MD
    J Am Acad Orthop Surg; 2018 Mar; 26(5):177-185. PubMed ID: 29419725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.